Similar articles

• Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.

  Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H. Ido A, et al. Cancer Res. 2001 Apr 1;61(7):3016-21. Cancer Res. 2001. PMID: 11306481
• Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.

  Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K. Mawatari F, et al. Cancer Gene Ther. 1998 Sep-Oct;5(5):301-6. Cancer Gene Ther. 1998. PMID: 9824049
• Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.

  Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K. Ishikawa H, et al. Biochem Biophys Res Commun. 2001 Oct 5;287(4):1034-40. doi: 10.1006/bbrc.2001.5684. Biochem Biophys Res Commun. 2001. PMID: 11573968
• The activation and silencing of gene transcription in the liver.

  Camper SA, Tilghman SM. Camper SA, et al. Biotechnology. 1991;16:81-7. Biotechnology. 1991. PMID: 1706634 Review. No abstract available.
• Molecular mechanisms of alpha-fetoprotein gene expression.

  Lazarevich NL. Lazarevich NL. Biochemistry (Mosc). 2000 Jan;65(1):117-33. Biochemistry (Mosc). 2000. PMID: 10702646 Review.